findmyKOL

Horacio Kaufmann, MD

Enriched profile

Felicia B. Axelrod Professor of Dysautonomia Research, Director of the Dysautonomia Center and Division of Autonomic Disorders, Professor of Medicine and Pediatrics, NYU Grossman School of Medicine · NYU Grossman School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyNeurologyFocusCardiovascular Syncope and Autonomic Disorders+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1986–2026

Horacio Kaufmann is Felicia B. Axelrod Professor of Dysautonomia Research, Director of the Dysautonomia Center and Division of Autonomic Disorders, Professor of Medicine and Pediatrics, NYU Grossman School of Medicine at NYU Grossman School of Medicine. OpenAlex indexes 596 publications with 30,903 citations (h-index 81); ClinicalTrials.gov lists 21 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 18 Oct 2026

Overview

Updated 18 Oct 2026

Horacio Kaufmann, M.D., is Felicia B. Axelrod Professor of Dysautonomia Research, Director of the Dysautonomia Center and Division of Autonomic Disorders, Professor of Medicine and Pediatrics, NYU Grossman School of Medicine. The public record shows 596 publications with 30,903 citations (h-index 81), centered on Cardiovascular Syncope and Autonomic Disorders, Parkinson's Disease Mechanisms and Treatments, Heart Rate Variability and Autonomic Control. It also documents an investigator role on 21 registered clinical trials, industry payments reported by 11 companies, 8 NIH-funded awards (1986–2026).

  • Most recent indexed publication: 2026 · Neurology
  • Top research focus: Cardiovascular Syncope and Autonomic Disorders
  • 21 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 11 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypotension8 trialsHypotension, Orthostatic8 trialsAutonomic Nervous System Diseases8 trialsDysautonomia, Familial8 trialsAtrophy5 trialsParkinson's Disease4 trialsdopamine beta hydroxylase deficiency4 trialsMultiple System Atrophy4 trialsPure Autonomic Failure3 trialsDiabetic Complications2 trialsAlzheimer's / Dementia2 trialsDementia2 trialsREM Sleep Behavior Disorder2 trialsShy-Drager Syndrome1 trialSyncope1 trialHyperhidrosis1 trialDiabetic Neuropathies1 trialHypertension1 trialAnxiety Disorders1 trialDysthymic Disorder1 trialSynucleinopathies1 trialHereditary Sensory and Autonomic Neuropathies1 trialVomiting1 trialNausea1 trial

Research focus

OpenAlex concept fingerprint
Cardiovascular Syncope and Autonomic DisordersParkinson's Disease Mechanisms and TreatmentsHeart Rate Variability and Autonomic ControlHereditary Neurological DisordersVestibular and auditory disorders

Drugs & molecules

across trials, industry payments and publications
Wainuageneric · EplontersenClinical trials—Industry payments1Publications—Yupelrigeneric · RevefenacinClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
NYU Langone HealthClinical trials12Industry payments—H. Lundbeck A SClinical trials—Industry payments10Chelsea TherapeuticsClinical trials4Industry payments—Ionis Pharmaceuticals, Inc.Clinical trials—Industry payments4Icahn School of Medicine at Mount SinaiClinical trials3Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments3Eli Lilly and CompanyClinical trials—Industry payments2Sanofi Us Services Inc.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Janssen Global Services, LLCClinical trials—Industry payments1Mylan Specialty L.P.Clinical trials—Industry payments1National Center for Research Resources (NCRR)Clinical trials1Industry payments—Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments1Sumitomo Pharma Co., Ltd.Clinical trials—Industry payments1Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments1Vanderbilt University Medical CenterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
596publications

Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.

30,903citations

Total citations across indexed works.

81h-index

Hirsch index (OpenAlex). i10-index 278.

Clinical & industry

trials, payments and federal funding
21clinical trials

Investigator role on registered studies.

View trials ↓
11companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
8NIH grants · 1986–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 21 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.1%
    Adrenergic and dopaminergic agents21.7%
    Droxidopa100%
    Part D≥14 patients
    alpha-Adrenergic Agonist15%
    Midodrine Hcl100%
    Part D≥24 patients

    + 2 more classes in this area

  • Nervous system

    26.6%
    Benzodiazepine8.8%
    Diazepam100%
    Part D<11 patients
    Aromatic Amino Acid Decarboxylation Inhibitor8.2%
    Carbidopa58%Carbidopa-Levodopa43%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    10.9%
    alpha-Glucosidase Inhibitor10.9%
    Acarbose100%
    Part D≥15 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

8 NIH research awards on record, funded 1986–2026 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jose‐Alberto Palma145Italo Biaggioni64Roy L. Freeman44Gregor Karl Wenning40Felicia Bliss Axelrod37Phillip A. Low35David S. Goldstein28Werner H Poewe25Wolfgang Singer25Patricio Millar Vernetti22Christopher H. Gibbons22Klaus Seppi22Alessandra Fanciulli21Jens Jordan20Cyndya A. Shibao18Vaughan Gary Macefield18Steven A. Vernino17Pietro Cortelli17Wassilios G. Meissner16Christopher J. Mathias15Florian Krismer15Wouter Wieling15Alejandra González‐Duarte15Carlos E. Mendoza‐Santiesteban15Miguel A. Perez14Ross G. Vickery13Joel Gutiérrez13Niall Patrick Quinn12William P. Cheshire12Satish R. Raj12Christy L. Spalink12Andrei Voustianiouk12Maria Teresa Pellecchia12Eduardo Elias Benarroch11Huw R. Morris11Jose M. Martinez11Dennis W. Dickson10Sonja W. Scholz10Geidy E. Serrano10Olivier Rascol10

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    nyulangone.org/doctors/1134190291/horacio-kaufmann

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Buenos Aires

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American Academy of Neurology (FAAN)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aan.com ↗
  • Program Director

    Autonomic Disorders Fellowship, NYU Grossman School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
  • Principal Investigator

    Natural History Study of the Synucleinopathies (NHSS), NINDS-funded

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →conductscience.com ↗
  • Principal Investigator

    Clinical Trial Readiness in MSA, NINDS-funded

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →conductscience.com ↗
  • Co-chair

    Task Force on Diagnostic Criteria for Multiple System Atrophy, Movement Disorder Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aan.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.